Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
02/14/2001 | CN1061851C Rhodospirillum preparation and its preparing method and application |
02/14/2001 | CN1061849C Prodn process of medicated royal jelly |
02/14/2001 | CN1061848C Injection for curing cystic and its prepn tech |
02/14/2001 | CN1061847C White ant oral liquid and its preparing process |
02/14/2001 | CN1061846C Traditional chinese medicine for tonifying kidney, reinforcing spleen and mourishing blood and its prepn process |
02/13/2001 | US6187744 Time-controlled superoxygenating compositions that comprise hemoglobin colloid and guanosine 3':5'-cyclic monophosphate (cyclic gmp) generating compounds |
02/13/2001 | US6187572 Decontaminating blood and cell cultures by mixing with a chemical radiation sensitizer which does not bind to the membrane, freezing or freeze-drying the mixture, then exposing to electromagnetic radiation |
02/13/2001 | US6187568 Culture product of actinoplane; immunosuppressant, fungicides, antitumor agents |
02/13/2001 | US6187307 Cancer immunotherapy with semi-allogeneic cells |
02/13/2001 | US6187306 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
02/13/2001 | CA2315588A1 Use of antithrombin iii for the prophylaxis and therapy of diseases |
02/13/2001 | CA2180977C Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light |
02/13/2001 | CA2160486C Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
02/13/2001 | CA2048619C Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
02/08/2001 | WO2001009616A2 Method for determining physiological effects of hemoglobin |
02/08/2001 | WO2001009609A2 Hepatitis c viral antigen immunoassay detection systems |
02/08/2001 | WO2001009361A1 Recombinant hsv-1 and live viral vaccines |
02/08/2001 | WO2001009342A1 Microencapsulated nitric oxide synthase source |
02/08/2001 | WO2001009325A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
02/08/2001 | WO2001009297A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
02/08/2001 | WO2001009288A1 Method for obtaining dendritic cells, resulting dendritic cells and uses thereof for clinical purposes |
02/08/2001 | WO2001009179A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
02/08/2001 | WO2001009115A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |
02/08/2001 | WO2001008716A1 Method of preservation of amnion and uses thereof |
02/08/2001 | WO2001008708A2 Enhanced delivery via serpin enzyme complex receptor ligands |
02/08/2001 | WO2001008694A2 Direct arterial infiltration for production of vascular pathology |
02/08/2001 | WO2001008691A1 Methods for transdifferentiation of body tissues |
02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
02/08/2001 | WO2001008609A1 Method and article to induce hematopoietic expansion |
02/08/2001 | WO2000076540A3 Streptococcus pneumoniae proteins and vaccines |
02/08/2001 | WO2000069449A3 Conditioned cell culture medium compositions and methods of use |
02/08/2001 | WO2000068261A3 Attenuated microorganisms for the treatment of infection |
02/08/2001 | WO2000067785A3 Staphyloccocus aureus antigen-containing whole cell vaccine |
02/08/2001 | WO2000067774A3 Materials for soft tissue augmentation and methods of making and using same |
02/08/2001 | WO2000067764A3 Improved method for treating mammals with modified mammalian blood |
02/08/2001 | WO2000066188A3 Xenotransplant for cns therapy |
02/08/2001 | WO2000066036A3 Fabrication of vascularized tissue using microfabricated two-dimensional molds |
02/08/2001 | WO2000063406A3 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules |
02/08/2001 | WO2000061772A3 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
02/08/2001 | WO2000061756A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
02/08/2001 | WO2000059525A3 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
02/08/2001 | DE19936563A1 Tumorassoziiertes Antigen Tumor-associated antigen |
02/08/2001 | CA2391348A1 Enhanced delivery via serpin enzyme complex receptor |
02/08/2001 | CA2381056A1 Recombinant hsv-1 and live viral vaccines |
02/08/2001 | CA2380787A1 Microencapsulated nitric oxide synthase source |
02/08/2001 | CA2380631A1 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
02/08/2001 | CA2380379A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
02/08/2001 | CA2380295A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
02/08/2001 | CA2378929A1 Serine proteases |
02/08/2001 | CA2378140A1 Methods for transdifferentiation of body tissues |
02/07/2001 | EP1074620A1 Monomeric protein of the TGF-beta family |
02/07/2001 | EP1074266A2 Live attenuated bacteria for use in a vaccine |
02/07/2001 | EP1073737A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
02/07/2001 | EP1073720A2 Efficient ex vivo expansion of cd4+ and cd8+ t-cells from hiv infected subjects |
02/07/2001 | EP1073683A1 G-csf receptor agonist antibodies and screening method therefor |
02/07/2001 | EP1073471A1 Method of treating endotoxemia |
02/07/2001 | EP1073456A1 Compositions and methods for the prevention and treatment of cardiovascular diseases |
02/07/2001 | EP1073445A1 Substance mixture for topical application comprising olive oil and honey |
02/07/2001 | EP1073444A1 A food composition and method of using same |
02/07/2001 | EP1073443A1 Method for preparing a diafiltered stabilized blood product |
02/07/2001 | EP1073442A1 Combination viral-based and gene-based therapy of tumors |
02/07/2001 | EP1073420A2 Specially devised neuronal implants for reconstruction of damaged central nervous system |
02/07/2001 | EP0556303B1 System and method for processing biological fluids |
02/07/2001 | CN1282603A Exterior-applied Chinese medicine for treating bone fracture and its preparing process |
02/07/2001 | CN1282594A Medical wine (Kepitong) for treating rheumatoid arthritis |
02/07/2001 | CN1282592A Plaster for treating bone diseases |
02/07/2001 | CN1282590A 三七胶囊 Thirty-seven Capsules |
02/07/2001 | CN1282589A Medical capsule for reinforcing vital energy of kidney and making body stronger |
02/07/2001 | CN1282586A Application of soft-shelled turtle blood |
02/07/2001 | CN1282575A Nutritive beautifying skin-protecting preparation containing colostrum fat of cow |
02/07/2001 | CN1061681C Health-care wine |
02/07/2001 | CN1061561C Health-care wine |
02/07/2001 | CN1061559C Medicine for treating myoma of uterus |
02/07/2001 | CN1061554C Chinese patent drug for treating hepatitis B |
02/07/2001 | CN1061552C Epilepsy recovering pill and preparing process thereof |
02/07/2001 | CN1061548C Wujie medicinal liquor for treating rheumatoid |
02/07/2001 | CN1061547C Nutritious oral liquid for improving quality and quantity of woman milk and preparation method thereof |
02/07/2001 | CN1061546C Preparation for treating burns and empyrosis and its preparing process |
02/07/2001 | CN1061545C Chinese medicine ointment for burn and its scar |
02/07/2001 | CN1061543C Compound pill for treating chronic bronchitis |
02/07/2001 | CN1061542C Medicine for treating mastadenitis |
02/07/2001 | CN1061537C Monascus preparation for hyperlipemia and relevant cardiac and cerebral disease |
02/07/2001 | CN1061536C Tablet for clearing head for cerebrorascular disease |
02/07/2001 | CN1061535C Method dissolving pearl and pearl honey tonic obtained by said method |
02/07/2001 | CN1061525C Crisp bone black-bone chicken and its producing precess |
02/06/2001 | US6184346 Peptide of defined amino acid sequence which inhibits elastase and subtilisin; use as drug because of low molecular weight |
02/06/2001 | US6184035 Modulation of cellular differentiation in bone associated tissues; culturing muscles tissues under preferential oxygen environment and monitoring development |
02/06/2001 | US6184033 Drug for the treatment of viral diseases |
02/06/2001 | US6184025 Nucleotide sequences for the detection and diagnosis of viral diseases |
02/06/2001 | US6183993 Complement-resistant non-mammalian DNA viruses and uses thereof |
02/06/2001 | US6183784 A plurality of cell growth stimulating factors, extracted from milk product, in concentrated form. cell culture compositions and pharmaceutical or veterinary compositions including the above milk product extract. |
02/06/2001 | US6183756 Methods for prevention and/or treatment of thrombocytopenia |
02/06/2001 | US6183737 Bonding of cartilage pieces using isolated chondrocytes and a biological gel |
02/06/2001 | US6183651 Blood processing systems and methods which optically monitor plasma opacity |
02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
02/05/2001 | CA2309313A1 Stimulation of the immune response by human dendritic cell manipulation |
02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
02/01/2001 | WO2001007637A2 Conditionally controlled, attenuated hiv vaccine |
02/01/2001 | WO2001007628A2 Human synthetases |
02/01/2001 | WO2001007605A1 Immunosuppression by cell surface expression of recombinant cd154 |